Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life

Trial ID or NCT#

NCT03021239

Status

recruiting iconRECRUITING

Purpose

The main purpose of this study is to compare Echo-guided testing to the Hemodynamic-Echo Ramp Tests to determine which method of testing provides better information for adjusting pump speed and medical treatment for Left Ventricular Assist Device (LVAD) patients. Better adjustments may provide better quality of life, exercise tolerance and reduced unwanted cardiac events over a 6-month period.

Official Title

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: A Multicenter Study

Eligibility Criteria

Ages Eligible for Study: 18 Years to 99 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Patient older than 18 years 2. Newly implanted HVAD 3. HVAD support anticipated for at least 6 months 4. Patient is ambulatory and discharged from hospital without inotropes 5. Patient is between 1 and 3 months post implant 6. Patient has not had a right heart catheterization since discharged from HVAD implantation hospitalization
Exclusion Criteria:
  1. 1. The current HVAD is a replacement device 2. Patients currently has Right Ventricle (RV) failure requiring home inotropes 3. Inability to preformed right heart cath 4. Inadequate echocardiographic windows
View All Criteria
Show Less

Contact us to find out if this trial is right for you.

Contact

Dip Banerjee, MD

View on ClinicalTrials.gov